Skip to main content

Table 2 Patient survival or disease progression associated with miR-145 expression in analyzed studies

From: Prognostic role of microRNA-145 in various human malignant neoplasms: a meta-analysis of 18 related studies

First author, year of publication, and reference

Assay method

Cut-off value

Cases, n

OS

PFSa

  

High expression

Low expression

HR (95% CI)

P

HR (95% CI)

P

Lee 2013 [5]

qRT-PCR

Mean

NM

NM

0.84 (0.74 to 0.97) (M)b

0.017

NM

NM

Saija 2013 [6]

Microarray

Three-fold

215

53

0.67 (0.49 to 0.92) (U)b

<0.01

NM

NM

Campayo 2013 [7]

qRT-PCR

Mean

56

14

NM

NM

0.30 (0.12 to 0.73) (M)b

0.015

Yu 2013 [11]

qRT-PCR

Two-fold

125

125

0.21 (0.14 to 0.31) (U)b

<0.01

NM

NM

Avgeris 2013 [20]

qRT-PCR

Mean

35

27

NM

NM

0.79 (0.31 to 2.04) (M)

0.629

Tang 2013 [21]

qRT-PCR

Median

77

89

0.28 (0.11 to 0.91) (M)

0.010

0.24 (0.09 to 0.83) (M)

0.008

Tanaka 2013 [22]

qRT-PCR

Median

32

32

NM

NM

0.89 (0.38 to 2.09) (U)b

0.809

Speranza 2012 [23]

qRT-PCR

Median

8

7

0.23 (0.06 to 0.83) (U)b

0.018

NM

NM

Kang 2012 [24]

qRT-PCR

Median

NM

NM

NM

NM

0.68 (0.22 to 2.14) (U)

0.510

Schee 2012 [25]

qRT-PCR

Median

96

97

NM

NM

1.41 (0.76 to 2.59) (U)b

0.290

Law 2012 [9]

qRT-PCR

1.5-fold

15

32

NM

NM

0.22 (0.09 to 0.57) (U)b

<0.05

Ko 2012 [12]

qRT-PCR

Two-fold

13

12

NM

NM

2.56 (1.06 to 6.18) (U)b

0.037

Huang 2012 [26]

qRT-PCR

Mean

22

22

0.47 (0.17 to 1.33) (M)b

0.072

NM

NM

Marchini 2011 [27]

qRT-PCR

Median

NM

NM

0.14 (0.03 to 0.75) (M)

0.022

2.24 (0.47 to 10.59) (M)

0.309

Radojicic 2011 [28]

qRT-PCR

Mean

38

49

1.19 (0.58 to 2.45) (U)b

0.824

1.04 (0.52 to 2.09) (U)b

0.882

Leite 2011 [13]

qRT-PCR

Mean

NM

NM

NM

NM

3.35 (1.32 to 8.50) (M)

0.011

Hamano 2011 [29]

qRT-PCR

Median

49

49

0.58 (0.33 to 0.99) (U)b

0.023

NM

NM

Drebber 2011 [30]

qRT-PCR

Median

35

15

0.38 (0.11 to 1.31) (U)b

0.244

NM

NM

  1. CI, confidence interval; DFS, disease-free survival; HR, hazard ratio; M, multivariate analysis; MFS, metastasis-free survival; NM, not mentioned; OS, overall survival; PFS, progression-free survival; qRT-PCR, quantitative real-time PCR; RFS, relapse-free survival; U, univariate analysis.
  2. aPFS included any of the following: DFS, MFS or RFS.
  3. bHR and 95% CI calculated by survival curve.